aztreonam has been researched along with metronidazole in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdelnasser, M; Serajuddin, AT; Thakur, AB; Wadke, DA | 1 |
| Edwardson, KF; Jones, J; Morris, DL; Pain, J; Slack, R; Strachan, C; Wilson, SR | 1 |
| Burdon, DW; Keighley, MR; Youngs, DJ | 1 |
| Bell, RG; Lipford, LC; Massanari, MJ; Riley, CM | 1 |
| Adamovics, J; Creasey, WA; Dhruv, R; Platt, TB; Sugerman, AA | 1 |
| Arora, V; Janning, SW | 1 |
| Danziger, LH | 2 |
| Bar-Ziv, J; Cohen, SE; Ligumsky, M; Safadi, R | 1 |
| Cheadle, WG; Cook, M; Hadjiminas, DJ; Heinzelmann, M; Mercer-Jones, MA; Peyton, J | 1 |
| Zingman, BS | 1 |
| Ceuppens, JL; Colpaert, S; De Greef, B; Geboes, K; Liu, Z; Rutgeerts, P | 1 |
| Knorr, JP; Moshfeghi, M; Sokoloski, MC | 1 |
| Dhanasekaran, S; Manoharan, SS; Selvadoss, PP | 1 |
| Gorroochurn, P; Han, D; Johnson, J; Movassaghi, M; Schulster, M; Shah, O; Villanueva, J | 1 |
1 review(s) available for aztreonam and metronidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for aztreonam and metronidazole
| Article | Year |
|---|---|
A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover.
Topics: Aztreonam; Bacterial Infections; Cefotaxime; Colon; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Metronidazole; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Rectum | 1990 |
21 other study(ies) available for aztreonam and metronidazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Interaction of metronidazole with antibiotics containing the 2-aminothiazole moiety.
Topics: Aztreonam; Color; Drug Interactions; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metronidazole; Nitrites | 1991 |
The penetration of aztreonam, a monobactam antibiotic, into intra-abdominal abscesses.
Topics: Abdomen; Abscess; Animals; Aztreonam; beta-Lactamases; Escherichia coli; Hydrogen-Ion Concentration; Male; Metronidazole; Models, Biological; Rats; Rats, Inbred Strains; Suppuration | 1989 |
Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
Topics: Aztreonam; Cefoxitin; Drug Combinations; Drug Stability; Drug Storage; Gentamicins; Glucose; Metronidazole; Sodium Chloride; Tobramycin | 1986 |
Pharmacokinetic interaction of aztreonam with other antibiotics.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cephradine; Clindamycin; Drug Interactions; Gentamicins; Humans; Kinetics; Male; Metronidazole; Nafcillin | 1984 |
More on prophylaxis with aztreonam plus metronidazole during appendectomy.
Topics: Appendectomy; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Metronidazole; Surgical Wound Infection | 1994 |
Prophylaxis with aztreonam plus metronidazole during appendectomy.
Topics: Appendectomy; Aztreonam; Bacterial Infections; Humans; Metronidazole; Surgical Wound Infection | 1993 |
Prophylaxis with aztreonam plus metronidazole during appendectomy.
Topics: Appendectomy; Aztreonam; Drug Therapy, Combination; Humans; Metronidazole; Surgical Wound Infection | 1993 |
Conservative therapy in an ERCP-induced abdominal abscess.
Topics: Abdominal Abscess; Adult; Ampicillin; Aztreonam; Cholangiopancreatography, Endoscopic Retrograde; Cholelithiasis; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Metronidazole; Tomography, X-Ray Computed | 1996 |
Continuous antibiotic treatment for experimental abdominal sepsis: effects on organ inflammatory cytokine expression and neutrophil sequestration.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Cefoxitin; Cephamycins; Cytokines; Endotoxins; Interleukin-1; Metronidazole; Mice; Peroxidase; Sepsis; Tumor Necrosis Factor-alpha | 1998 |
Fever after cytotoxic therapy of chronic lymphocytic leukemia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aztreonam; Candidiasis; Female; Fever; Glycopeptides; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Metronidazole; Middle Aged; Monobactams; Vidarabine | 1999 |
Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aztreonam; Bacteria, Anaerobic; Crohn Disease; Disease Models, Animal; Drug Therapy, Combination; Female; Indomethacin; Inflammation; Interleukin-10; Metronidazole; Monobactams; Permeability; Rats; Rats, Wistar; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2001 |
Ciprofloxacin-induced Q-T interval prolongation.
Topics: Abscess; Acetamides; Adolescent; Anti-Infective Agents; Aztreonam; Bradycardia; Ciprofloxacin; Crohn Disease; Humans; Infusions, Intravenous; Linezolid; Long QT Syndrome; Male; Metronidazole; Oxazolidinones; Randomized Controlled Trials as Topic | 2008 |
Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach.
Topics: Anti-Bacterial Agents; Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Aztreonam; Candida albicans; Candidiasis; Clindamycin; Drug Repositioning; Humans; Meropenem; Metronidazole | 2023 |
Antimicrobial Prophylaxis for Percutaneous Nephrolithotomy: Contemporary Practice Patterns.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Humans; Metronidazole; Nephrolithotomy, Percutaneous; Urology | 2023 |